perfosfamide has been researched along with novobiocin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flannery, DJ; Lee, FY; Siemann, DW | 1 |
| Davidson, NE; Davis, J; Huelskamp, AM; Kennedy, MJ; Noga, SJ; Ohly, K; Passos-Coelho, J | 1 |
2 other study(ies) available for perfosfamide and novobiocin
| Article | Year |
|---|---|
Modulation of the cell cycle-dependent cytotoxicity of adriamycin and 4-hydroperoxycyclophosphamide by novobiocin, an inhibitor of mammalian topoisomerase II.
Topics: Animals; Cell Cycle; Cell Line; Cell Survival; Cyclophosphamide; Doxorubicin; Glutathione; Novobiocin; Topoisomerase I Inhibitors | 1992 |
Administration of human recombinant granulocyte colony-stimulating factor (filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow in women with m
Topics: Adult; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Length of Stay; Leukocyte Count; Middle Aged; Neutrophils; Novobiocin; Recombinant Proteins; Thiotepa | 1993 |